Clear Wave Wealth Management’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$256K Hold
10,792
– – 0.04% 155
2026
Q2
$262K Buy
+10,792
New +$184K 0.05% 157

Other funds holding NRIX

Clear Wave Wealth Management's NRIX Position: Q3 2026 in Review

Clear Wave Wealth Management held its Nurix Therapeutics (NRIX) position steady in Q3 2026 at 10,792 shares worth $256K. The position accounts for 0.04% of the portfolio, ranked #155.

Clear Wave Wealth Management first reported a position in NRIX in Q2 2026 and has held it in 2 quarters since. The position peaked at $262K in Q2 2026. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Clear Wave Wealth Management held 10,792 shares of Nurix Therapeutics worth $256K as of Q3 2026.
  • Clear Wave Wealth Management left its Nurix Therapeutics share count unchanged in Q3 2026.
  • Nurix Therapeutics made up 0.04% of Clear Wave Wealth Management's portfolio in Q3 2026, its #155 holding.
  • Clear Wave Wealth Management first reported a position in Nurix Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Clear Wave Wealth Management's Nurix Therapeutics position peaked at $262K in Q2 2026.
  • 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Clear Wave Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.